A retrospective chart review analysis of refractory CU patients unresponsive to high-dose H1-blockers and immunomodulators and subsequently treated with omalizumab at the University of Wisconsin Allergy Clinic was performed with particular focus on their autoimmune characteristics, response to therapy, and ...
The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart reviewAlthough the most severe of the allergic disorders, the epidemiology of anaphylaxis remains poorly described. Hospital admissions for anaphylaxis in England more than doubled during the 19...
No prespecified dosing protocol was followed, and dosing varied in our study. The doses of omalizumab given to all patients are shown in Supplemental Figure 1. Initial doses chosen and adjustment of the dosage were based on disease activity and disease control status. Time to respond to omalizu...
Asthma is a chronic condition with characteristics that make it an ideal target for interventions used within disease state management in managed care sett